Defining the high-risk category of patients with cutaneous melanoma: a practical tool based on prognostic modeling
IntroductionAlthough most cutaneous melanoma (CM) in its early stages is treatable, the risk of recurrence remains high and there is a particular ambiguity on patients prognosis. This drives to identification of prognostic biomarkers for predicting CM recurrence to guide appropriate treatment in pat...
Saved in:
Main Authors: | Oleksandr Dudin, Ozar Mintser, Vitalii Gurianov, Nazarii Kobyliak, Denys Kozakov, Sofiia Livshun, Oksana Sulaieva |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2025.1543148/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Melanoma genomics – will we go beyond BRAF in clinics?
by: Justyna Mirek, et al.
Published: (2024-09-01) -
CRIP1 inhibits cutaneous melanoma progression through TFAM-mediated mitochondrial biogenesis
by: Jianqiang Wu, et al.
Published: (2025-02-01) -
Editorial: Cutaneous vasculitis and vasculopathy
by: Erkan Alpsoy, et al.
Published: (2025-02-01) -
Insights into the transmission cycle of cutaneous leishmaniasis from an endemic community in rural Guatemala
by: Yaimie Lopez, et al.
Published: (2025-01-01) -
Vitiligo and cutaneous malignancy: what is the risk?
by: Sahngeun Jenny Mun, et al.
Published: (2024-12-01)